Skip to content

Cost-effectiveness of a management program after hospital discharge in older patients with heart failure

Cost-effectiveness of a disease management program after hospital discharge in older patients with heart failure delivered by geriatric day hospital versus usual care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10823032
Enrollment
112
Registered
2012-01-27
Start date
2007-03-02
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure in the elderly Circulatory System Heart failure

Interventions

Intervention group: The disease management program (DMP) had four main components: 1. Educational intervention on management of heart failure to improve patient and car

Sponsors

Our Lady of the Mountain Hospital, Caceres (Hospital Nuestra Señora de la Montaña) (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged over 65 2. Discharged home or to a nursing home without medical staff after a hospitalization due to heart failure of at least 48 hours of hospital stay (determined according to the European Society of Cardiology guidelines)

Exclusion criteria

Exclusion criteria: 1. Planned discharge to a long-term care facility or nursing home with medical staff 2. Severe dementia or other serious psychiatric illness 3. Confined to bed 4. Anticipated survival of less than 6 months 5. Foreseeable follow-up problems such as residence outside the hospital catchment area 6. Refusal to participate

Design outcomes

Primary

MeasureTime frame
1. Estimated event-free survival, defined on the basis of time to first event (any cause readmission or death) at 1 year. Kaplan?Meier survival curves will be constructed to assess differences in deaths or readmissions between groups and compared using the log rank test. Data for all event-free patients will be censored on study day 365. Event-free survivals will be tested with the Cox proportional hazards method. 2. Cost-effectiveness analysis. We will estimate costs from a societal perspective and will be included medical and non-medical costs. The effectiveness will be expressed in Quality-Adjusted Life Years (QALY) and will be calculated from the data of the Health Related Quality of Life (HRQL) obtained from the generic EuroQol-5D questionnaire.

Secondary

MeasureTime frame
1. Evaluate health-related quality of life: For health-related quality of life, the Minnesota Living With Heart Failure Questionnaire (MLWHFQ) score at baseline and 12 months will be calculated for each group in the trial. The effect of the DMP on quality of life will be estimated as the difference between groups in the change in MLWHFQ scores during the study. 2. Functional status: Assessed as ability to perform basic activities of daily living, the Barthel index (BI) score at baseline and 12 months will be calculated for each group in the trial. The effect of the DMP on functional status will be estimated as the difference between groups in the change in BI scores during the study.

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 6, 2026